This study seeks to characterize the genetic expression profiles and functions of peripheral blood PD‐1 (+) cells and how chiamide impacts circulating PD‐1 (+) cells of patients with PTCL in order to further explore the impact of circulating immune cells in tumor immunity. This evidence concerns the gene PDCD1 and mature T-cell and NK-cell non-Hodgkin lymphoma.